These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26769917)

  • 21. Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley rats.
    Thomas AM; Cargile KJ; Lunn JA; Baker LE
    Behav Pharmacol; 2021 Sep; 32(6):524-532. PubMed ID: 34397448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
    Cameron K; Kolanos R; Vekariya R; De Felice L; Glennon RA
    Psychopharmacology (Berl); 2013 Jun; 227(3):493-9. PubMed ID: 23371489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jan; 208(1):12-5. PubMed ID: 22008731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice.
    Gannon BM; Russell LN; Modi MS; Rice KC; Fantegrossi WE
    Drug Alcohol Depend; 2017 Oct; 179():408-415. PubMed ID: 28866386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics of racemic MDPV and its (R) and (S) enantiomers in female and male rats.
    Hambuchen MD; Hendrickson HP; Gunnell MG; McClenahan SJ; Ewing LE; Gibson DM; Berquist MD; Owens SM
    Drug Alcohol Depend; 2017 Oct; 179():347-354. PubMed ID: 28844011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystallographic investigations of select cathinones: emerging illicit street drugs known as `bath salts'.
    Wood MR; Lalancette RA; Bernal I
    Acta Crystallogr C Struct Chem; 2015 Jan; 71(Pt 1):32-8. PubMed ID: 25567572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) and structurally related synthetic cathinones.
    Seaman RW; Doyle MR; Sulima A; Rice KC; Collins GT
    Behav Pharmacol; 2021 Aug; 32(5):357-367. PubMed ID: 33587482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines.
    Kohler RJ; Perrine SA; Baker LE
    Neuropharmacology; 2018 May; 134(Pt A):22-27. PubMed ID: 29042316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats.
    Huang PK; Aarde SM; Angrish D; Houseknecht KL; Dickerson TJ; Taffe MA
    Drug Alcohol Depend; 2012 Nov; 126(1-2):168-75. PubMed ID: 22664136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.
    Simmons SJ; Gregg RA; Tran FH; Mo L; von Weltin E; Barker DJ; Gentile TA; Watterson LR; Rawls SM; Muschamp JW
    Addict Biol; 2018 Jan; 23(1):102-110. PubMed ID: 27910188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.
    Harvey EL; Baker LE
    Psychopharmacology (Berl); 2016 Feb; 233(4):673-80. PubMed ID: 26558618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and chronic neurobehavioral effects of the designer drug and bath salt constituent 3,4-methylenedioxypyrovalerone in the rat.
    Atehortua-Martinez LA; Masniere C; Campolongo P; Chasseigneaux S; Callebert J; Zwergel C; Mai A; Laplanche JL; Chen H; Etheve-Quelquejeu M; Mégarbane B; Benturquia N
    J Psychopharmacol; 2019 Mar; 33(3):392-405. PubMed ID: 30644332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology.
    De Felice LJ; Glennon RA; Negus SS
    Life Sci; 2014 Feb; 97(1):20-6. PubMed ID: 24231923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological mechanisms underlying the cardiovascular effects of the "bath salt" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Schindler CW; Thorndike EB; Suzuki M; Rice KC; Baumann MH
    Br J Pharmacol; 2016 Dec; 173(24):3492-3501. PubMed ID: 27714779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats.
    Berquist MD; Traxler HK; Mahler AM; Baker LE
    Drug Alcohol Depend; 2016 Jul; 164():128-134. PubMed ID: 27181413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.
    Baumann MH; Bukhari MO; Lehner KR; Anizan S; Rice KC; Concheiro M; Huestis MA
    Curr Top Behav Neurosci; 2017; 32():93-117. PubMed ID: 27830575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditioned place preference following concurrent treatment with 3, 4-methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats.
    Risca HI; Zuarth-Gonzalez JD; Baker LE
    Pharmacol Biochem Behav; 2020 Nov; 198():173032. PubMed ID: 32888971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
    Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ
    Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.
    Nguyen JD; Bremer PT; Ducime A; Creehan KM; Kisby BR; Taffe MA; Janda KD
    Neuropharmacology; 2017 Apr; 116():1-8. PubMed ID: 27956054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reinforcing Effects of Binary Mixtures of Common Bath Salt Constituents: Studies with 3,4-Methylenedioxypyrovalerone (MDPV), 3,4-Methylenedioxymethcathinone (methylone), and Caffeine in Rats.
    Gannon BM; Galindo KI; Mesmin MP; Rice KC; Collins GT
    Neuropsychopharmacology; 2018 Mar; 43(4):761-769. PubMed ID: 28677665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.